J.P. Morgan Healthcare Conference
Local expertise. Global resources.
Yellow AI Summary
The J.P. Morgan Healthcare Conference, held annually in San Francisco, convenes over 10,000 attendees from the healthcare and MedTech sectors, including CEOs from leading pharmaceutical companies like Merck, Pfizer, and Novartis. This four-day event, taking place January 11-14, 2027, at The Westin St. Francis, facilitates concentrated investor outreach and strategic partnership discussions across commercial banking, investment banking, and asset management. Its distinctive format enables direct engagement with key industry players and has been noted for signaling industry turning points and a rise in dealmaking.
Yellow Score Breakdown
Yellow's Take
This is the premier destination for healthcare and MedTech companies looking to accelerate investor outreach and forge strategic partnerships, drawing over 10,000 high-caliber attendees and featuring leadership from industry giants like Eli Lilly. While the event's focus and scale are undeniable strengths, marketers will need to directly inquire about crucial exhibitor and sponsorship investment details. Its deep industry niche and massive attendee count make it an unparalleled opportunity for targeted B2B engagement.
Attendee/Press Sentiment
Attendee Feedback Sentiment
Press Reviews Sentiment
“The JP Morgan Annual Healthcare Conference is often described as the Super Bowl of healthcare gatherings where major deals are born.”
Press Reviews
“After the dreary biotech winter of the last several years, J.P. Morgan Conference signaled an industry turning point with pragmatic optimism.”
“So is J.P. Morgan really worth all the fuss? Yes — the efficiency of having thousands of potential partners in one square mile is unmatched.”
“The JPMorgan Healthcare Conference 2026 reflected the industry's shift from speculative ambition to disciplined execution to convert innovation into durable value.”
“$1,200 a night for a hotel room and $20 for a coffee because they can charge it. JPM is the stage where deals are made.”
“Conversations at JPM 2026 made clear that dealmaking is on the rise, with portfolio-shaping transactions gaining momentum.”
“In 2026, approximately 12,000 investor one-on-one meetings were scheduled for 9,000 official attendees, demonstrating intense engagement.”
“Get the inside view of the 2026 J.P. Morgan Healthcare Conference with STAT reporters on the ground. More than 500 company presentations attracted thousands of global stakeholders.”
“At FINN Partners, we view JPM as the annual state of the union for life sciences — the most efficient forum to showcase progress.”
“The top 5 takeaways from J.P. Morgan's 2026 healthcare conference: Top CMS officials meet with industry to address healthcare's most persistent challenges.”
Topics
Speakers
Robert Davis
Chairman and CEO, Merck
Albert Bourla
Chairman and CEO, Pfizer
Vas Narasimhan
CEO, Novartis
Past Speakers (2025)
Albert Bourla
Chairman and CEO, Pfizer
Robert A. Bradway
Chairman and CEO, Amgen
Giovanni Caforio
Chairman, Bristol-Myers Squibb
David Ricks
Chairman and CEO, Eli Lilly
Paul Hudson
CEO, Sanofi
Vas Narasimhan
CEO, Novartis
Exhibitor & Booth Pricing
No exhibitor pricing found for this event.
Coupons
No coupons found for this event.
Sponsors
Thinking of exhibiting atJ.P. Morgan Healthcare Conference?
Research and analyze all events for your yearly programming, specifically scored and ranked for your ICP. Enrich attendee lists, draft and send personalized messages – before and immediately after the event.
and
